GlaxoSmithKline (GSK) announces that at today's Annual General
Meeting all resolutions, including
those electing
and re-electing Board members, were passed by shareholders.
The following table shows the votes cast for each resolution:
| Resolution | Total Votes For* | % | Total Votes Against | % | Total Votes Cast | Abstentions ** | |
|---|---|---|---|---|---|---|---|
| 1. | Adoption of Financial Statements | 3,906,841,624 |
98.79% |
47,758,594 |
1.21% |
3,954,600,218 |
175,150,362 |
| 2. | Approval of the Remuneration Report | 3,800,433,274 |
95.40% |
183,067,146 |
4.60% |
3,983,500,420 |
146,250,160 |
| 3. | Election of Sir Christopher Gent | 4,099,468,431 |
99.62% |
15,431,801 |
0.38% |
4,114,900,232 |
14,850,348 |
| 4. | Election of Sir Deryck Maughan | 4,104,142,353 |
99.75% |
10,428,930 |
0.25% |
4,114,571,283 |
15,179,297 |
| 5. | Election of Mr J Heslop | 4,100,614,116 |
99.66% |
14,129,375 |
0.34% |
4,114,743,491 |
15,007,089 |
| 6. | Re- election of Dr J- P Garnier | 4,099,153,866 |
99.61% |
15,882,823 |
0.39% |
4,115,036,689 |
14,713,891 |
| 7. | Re- election of Sir Ian Prosser | 4,103,392,185 |
99.73% |
11,267,847 |
0.27% |
4,114,660,032 |
15,090,548 |
| 8. | Re- election of Dr R Schmitz | 4,103,662,925 |
99.74% |
10,802,992 |
0.26% |
4,114,465,917 |
15,284,663 |
| 9. | Re- election of Dr L Shapiro | 4,096,777,184 |
99.57% |
17,647,353 |
0.43% |
4,114,424,537 |
15,326,043 |
| 10. | Re- appointment of Auditors | 4,055,015,241 |
99.48% |
21,364,410 |
0.52% |
4,076,379,651 |
53,370,929 |
| 11. | Remuneration of Auditors | 4,098,763,019 |
99.62% |
15,675,183 |
0.38% |
4,114,438,202 |
15,312,378 |
| 12. | Authorise donations to EU Political Organisations and incur EU Political Expenditure | 4,024,458,274 |
98.08% |
78,854,300 |
1.92% |
4,103,312,574 |
26,438,006 |
| 13. | Disapplication of pre- emption rights*** | 4,067,878,763 |
99.05% |
39,147,397 |
0.95% |
4,107,026,160 |
22,724,420 |
| 14. | Authority for the Company to purchase its own shares*** | 4,106,321,241 |
99.80% |
8,129,177 |
0.20% |
4,114,450,418 |
15,300,162 |
| 15. | Insertion of new Articles 48A into the Articles of Association*** | 4,088,185,649 |
99.84% |
6,721,259 |
0.16% |
4,094,906,908 |
34,843,672 |
| 16. | Deletion of Article 154.2 of the Articles of Association*** | 4,087,140,974 |
99.79% |
8,426,154 |
0.21% |
4,095,567,128 |
34,183,452 |
| 17. | Amendment to Article 81 of the Articles of Association*** | 4,090,361,524 |
99.88% |
5,032,818 |
0.12% |
4,095,394,342 |
34,356,238 |
Notes:
* Includes discretionary votes.
** An abstention is not a vote in law and is not counted in the
calculation of the proportion of votes "For" or
"Against" a
resolution.
*** Indicates Special Resolutions requiring a 75% majority
The following table provides further relevant information:
GlaxoSmithKline's Fifth AGM (2005) |
GlaxoSmithKline's Fourth AGM (2004) |
|
|---|---|---|
| Issued share capital (excluding Treasury Shares) |
5,852,415,354 |
5,921,564,431 |
| Total votes cast and abstentions lodged as a % of GSK's issued share capital (excluding Treasury Shares). | 70.56% |
66.75% |
| Total shareholder population. | 209,029 |
230,939 |
| Total number of proxies lodged. | 16,156 |
17,400 |
| % of shareholders who lodged proxies. | 7.73% |
7.53% |
| Number of shareholders, corporate representatives and proxies who attended the AGM | 286 |
349 |
S M Bicknell
Company Secretary
25th May 2005
Back to top